Depressive Disorders and Bipolar and Related Disorders

  • Rajesh R. Tampi
  • Deena J. Tampi
  • M. Ingre Walters
  • Geetha Manikkara
  • Poorvanshi Alag
  • Garima Garg


Depressive disorders and bipolar and related disorders are not uncommon among older adults. These disorders are associated with significant morbidity and mortality among individuals who suffer from them. Additionally, the neurobiology these disorders indicate greater burden of medical comorbidities. These disorders are often under- or misdiagnosed among older adults due to limited awareness of their prevalence, lack of standardized diagnostic protocols, and the ageist attitudes toward older adults with psychiatric disorders. Emerging data indicates the efficacy for both psychotherapy and pharmacotherapy in the management of these disorders. In this chapter we review the epidemiology, neurobiology, diagnosis, and the available treatments for these important disorders among older adults.


Depression Suicides Psychotherapy Antidepressants Bipolar disorder Lithium Anticonvulsants 


  1. 1.
    American Psychiatric Association. Desk reference to the diagnostic criteria from DSM-5, Depressive disorders. Washington DC: American Psychiatric Publishing; 2013. p. 93–114.Google Scholar
  2. 2.
    Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475):1961–70.CrossRefPubMedGoogle Scholar
  3. 3.
    Fountoulakis KN, O’Hara R, Iacovides A, et al. Unipolar late-onset depression: a comprehensive review. Ann Gen Hosp Psychiatry. 2003;2(1):11.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Alexopoulos GS. New concepts for prevention and treatment of late-life depression. Am J Psychiatry. 2001;158(6):835–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Harman JS, Schulberg HC, Mulsant BH, et al. The effect of patient and visit characteristics on diagnosis of depression in primary care. J Fam Pract. 2001;50(12):1068.PubMedGoogle Scholar
  6. 6.
    Taylor WD, Doraiswamy PMA. systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. Neuropsychopharmacology. 2004;29(12):2285–99.CrossRefPubMedGoogle Scholar
  7. 7.
    Mulsant BH, Ganguli M. Epidemiology and diagnosis of depression in late life. J Clin Psychiatry. 1999;60(Suppl 20):9–15.PubMedGoogle Scholar
  8. 8.
    Unutzer J, Katon W, Russo J, et al. Patterns of care for depressed older adults in a large-staff model HMO. Am J Geriatr Psychiatry. 1999;7(3):235–43.CrossRefPubMedGoogle Scholar
  9. 9.
    Dunner DL. Treatment considerations for depression in the elderly. CNS Spectr. 2003;8(12 Suppl 3):14–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Hegeman JM, Kok RM, van der Mast RC, Giltay EJ. Phenomenology of depression in older compared with younger adults: meta-analysis. Br J Psychiatry. 2012;200(4):275–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Thorpe L. The treatment of psychotic disorders in late life. Can J Psychiatr. 1997;42(Suppl 1):19S–27S.Google Scholar
  12. 12.
    Myers JK, Weissman MM, Tischler GL, et al. Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Arch Gen Psychiatry. 1984;41(10):959–67.CrossRefPubMedGoogle Scholar
  13. 13.
    Gournellis R, Lykouras L, Fortos A, et al. Psychotic (delusional) major depression in late life. Int J Geriatr Psychiatry. 2001;16(11):1085–91.CrossRefPubMedGoogle Scholar
  14. 14.
    Raskind MA. The clinical interface of depression and dementia. J Clin Psychiatry. 1998;59(Suppl 10):9–12.PubMedGoogle Scholar
  15. 15.
    Wang S, Blazer DG. Depression and cognition in the elderly. Annu Rev. Clin Psychol. 2015;11:331–60.CrossRefGoogle Scholar
  16. 16.
    Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79(2):184–90.CrossRefPubMedGoogle Scholar
  17. 17.
    Reynolds CF 3rd, Smith GS, Dew MA, et al. Accelerating symptom-reduction in late-life depression: a double-blind, randomized, placebo-controlled trial of sleep deprivation. Am J Geriatr Psychiatry. 2005;13(5):353–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Weisenbach SL, Kumar A. Current understanding of the neurobiology and longitudinal course of geriatric depression. Curr Psychiatry Rep. 2014;16(9):463.CrossRefPubMedGoogle Scholar
  19. 19.
    Alexopoulos GS, Katz IR, Reynolds CF, et al. Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract. 2001;7(6):361–76.CrossRefPubMedGoogle Scholar
  20. 20.
    Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA. 1993;270(15):1819–25.CrossRefPubMedGoogle Scholar
  21. 21.
    Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry. 2003;54(3):241–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Yaffe K, Blackwell T, Gore R, et al. Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry. 1999;56(5):425–30.CrossRefPubMedGoogle Scholar
  23. 23.
    Comijs HC, Jonker C, Beckman AT, Deeg DJ. The association between depressive symptoms and cognitive decline in community-dwelling elderly persons. Int J Geriatr Psychiatry. 2001;16(4):361–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59(3):364–70.CrossRefPubMedGoogle Scholar
  25. 25.
    Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288(3):351–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Katon W, Lin E, von Korff M, et al. The predictors of persistence of depression in primary care. J Affect Disord. 1994;31(2):81–90.CrossRefPubMedGoogle Scholar
  27. 27.
    Lynch TR, Johnson CS, Mendelson T, et al. New onset and remission of suicidal ideation among a depressed adult sample. J Affect Disord. 1999;56(1):49–54.CrossRefPubMedGoogle Scholar
  28. 28.
    Duberstein PR. Openness to experience and completed suicide across the second half of life. Int Psychogeriatr. 1995;7(2):183–98.CrossRefPubMedGoogle Scholar
  29. 29.
    Bruce ML. Psychosocial risk factors for depressive disorders in late life. Biol Psychiatry. 2002;52(3):175–84.CrossRefPubMedGoogle Scholar
  30. 30.
    Clyburn LD, Stones MJ, Hadjistavropoulos T, Tuokko H, et al. Predicting caregiver burden and depression in Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci. 2000;55(1):S2–S13.CrossRefPubMedGoogle Scholar
  31. 31.
    Cole MG, Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry. 2003;160(6):1147–56.CrossRefPubMedGoogle Scholar
  32. 32.
    Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry. 2005;162(9):1588–601.CrossRefPubMedGoogle Scholar
  33. 33.
    Hall CA, CF R-III. Late-life depression in the primary care setting: challenges, collaborative care, and prevention. Maturitas. 2014;79(2):147–52.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Goff VV. Depression: a decade of progress, more to do. NHPF Issue Brief. 2002;786:1–14.Google Scholar
  35. 35.
    Michelson D, Stratakis C, Hill L, et al. Bone mineral density in women with depression. N Engl J Med. 1996;335(16):1176–81.CrossRefPubMedGoogle Scholar
  36. 36.
    Ferketich AK, Schwartzbaum JA, Frid DJ, et al. Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med. 2000;160(9):1261–8.CrossRefPubMedGoogle Scholar
  37. 37.
    Glover J, Srinivasan S. Assessment of the person with late-life depression. Psychiatr Clin North Am. 2013;36(4):545–60.CrossRefPubMedGoogle Scholar
  38. 38.
    Diniz BS, Butters MA, Albert SM, et al. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329–35.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Turvey CL, Conwell Y, Jones MP, et al. Risk factors for late-life suicide: a prospective, community-based study. Am J Geriatr Psychiatry. 2002;10(4):398–406.CrossRefPubMedGoogle Scholar
  40. 40.
    Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA. 1992;267(11):1478–83.CrossRefPubMedGoogle Scholar
  41. 41.
    Croghan TW, Obenchain RL, Crown WE. What does treatment of depression really cost? Health Aff. 1998;17(4):198–208.CrossRefGoogle Scholar
  42. 42.
    Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465–75.CrossRefPubMedGoogle Scholar
  43. 43.
  44. 44.
    Mulkeen A, Zdanys K, Muralee S, et al. Screening tools for late-life depression: a review. Depression: Mind and Body. 2008;3(4):150–7.Google Scholar
  45. 45.
    Lichtenberg PA, Marcopulos BA, Steiner DA, et al. Comparison of the Hamilton Depression Rating Scale and the Geriatric Depression Scale: detection of depression in dementia patients. Psychol Rep. 1992;70:515–21.CrossRefPubMedGoogle Scholar
  46. 46.
    Clayton AH, Holroyd S, Sheldon-Keller A. Geriatric depression scale vs Hamilton rating scale for depression in a sample of anxiety patients. Clin Gerontol. 1997;17:3–13.CrossRefGoogle Scholar
  47. 47.
    Benjamin S, Steffens DC. Structural neuroimaging of geriatric depression. Psychiatr Clin North Am. 2011;34(2):423–35.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Gunning FM, Smith GS. Functional neuroimaging in geriatric depression. Psychiatr Clin North Am. 2011;34(2):403–22.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Bartels SJ, Coakley EH, Zubritsky C, et al. Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use. Am J Psychiatry. 2004;161(8):1455–62.CrossRefPubMedGoogle Scholar
  50. 50.
    Hunkeler EM, Meresman JF, Hargreaves WA, et al. Efficacy of nurse telehealth care and peer support in augmenting treatment of depression in primary care. Arch Fam Med. 2000;9(8):700–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Sherbourne CD, Wells KB, Duan N, et al. Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psychiatry. 2001;58(7):696–703.CrossRefPubMedGoogle Scholar
  52. 52.
    Cuijpers P, van Lammeren P. Secondary prevention of depressive symptoms in elderly inhabitants of residential homes. Int J Geriatr Psychiatry. 2001;16(7):702–8.CrossRefPubMedGoogle Scholar
  53. 53.
    Hunkeler EM, Katon W, Tang L, et al. Long term outcomes from the IMPACT randomised trial for depressed elderly patients in primary care. BMJ. 2006;332(7536):259–63.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Mulsant BH, Alexopoulos GS, Reynolds CF, et al. Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm. Int J Geriatr Psychiatry. 2001;16(6):585–92.CrossRefPubMedGoogle Scholar
  55. 55.
    Bruce ML, Ten Have TR, Reynolds CF, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291(9):1081–91.CrossRefPubMedGoogle Scholar
  56. 56.
    Alexopoulos GS, Katz IR, Bruce ML, et al. Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry. 2005;162(4):718–24.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Mulsant BH, Blumberger DM, Ismail Z, et al. A systematic approach to pharmacotherapy for geriatric major depression. Clin Geriatr Med. 2014;30(3):517–34.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Knöchel C, Alves G, Friedrichs B, et al. Treatment-resistant late-life depression: challenges and perspectives. Curr Neuropharmacol. 2015;13(5):577–91.CrossRefPubMedPubMedCentralGoogle Scholar
  59. 59.
    Sjosten N, Kivela SL. The effects of physical exercise on depressive symptoms among the aged: a systematic review. Int J Geriatr Psychiatry. 2006;21(5):410–8.CrossRefPubMedGoogle Scholar
  60. 60.
    Mackin RS, Areán PA. Evidence-based psychotherapeutic interventions for geriatric depression. Psychiatr Clin North Am. 2005;28(4):805–20, vii–viiiCrossRefPubMedGoogle Scholar
  61. 61.
    Cuijpers P, van Straten A, Smit F. Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials. Int J Geriatr Psychiatry. 2006;21(12):1139–49.CrossRefPubMedGoogle Scholar
  62. 62.
    Pinquart M, Duberstein PR, Lyness JM. Effects of psychotherapy and other behavioral interventions on clinically depressed older adults: a meta-analysis. Aging Ment Health. 2007;11(6):645–57.CrossRefPubMedGoogle Scholar
  63. 63.
    Wilson KC, Mottram PG, Vassilas CA. Psychotherapeutic treatments for older depressed people. Cochrane Database Syst Rev. 2008;1:CD004853.Google Scholar
  64. 64.
    Kiosses DN, Leon AC, Areán PA. Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects. Psychiatr Clin North Am. 2011;34(2):377–401, viiiCrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Cuijpers P, Karyotaki E, Pot AM, et al. Managing depression in older age: psychological interventions. Maturitas. 2014;79(2):160–9.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Huang AX, Delucchi K, Dunn LB, Nelson JCA. systematic review and meta-analysis of psychotherapy for late-life depression. Am J Geriatr Psychiatry. 2015;23(3):261–73.CrossRefPubMedGoogle Scholar
  67. 67.
    Nelson JC, Delucchi K, Schneider LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry. 2008;16(7):558–67.CrossRefPubMedGoogle Scholar
  68. 68.
    Mukai Y, Tampi RR. Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants. Clin Ther. 2009;31(5):945–61.CrossRefPubMedGoogle Scholar
  69. 69.
    Tollefson GD, Bosomworth JC, Heiligenstein JH, et al. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. Int Psychogeriatr. 1995;7(1):89–104.CrossRefPubMedGoogle Scholar
  70. 70.
    Allard P, Gram L, Timdahl K, et al. Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram. Int J Geriatr Psychiatry. 2004;19(12):1123–30.CrossRefPubMedGoogle Scholar
  71. 71.
    Nelson JC, Wohlreich MM, Mallinckrodt CH, et al. Duloxetine for the treatment of major depressive disorder in older patients. Am J Geriatr Psychiatry. 2005;13(3):227–35.CrossRefPubMedGoogle Scholar
  72. 72.
    Schatzberg AF, Kremer C, Rodrigues HE, et al. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Am J Geriatr Psychiatry. 2002;10(5):541–50.CrossRefPubMedGoogle Scholar
  73. 73.
    Posternak MA, Zimmerman M. Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients. J Clin Psychiatry. 2001;62(2):135–42.CrossRefPubMedGoogle Scholar
  74. 74.
    Kamholz BA, Mellow AM. Management of treatment resistance in the depressed geriatric patient. Psychiatr Clin North Am. 1996;19(2):269–86.CrossRefPubMedGoogle Scholar
  75. 75.
    Whyte EM, Basinski J, Farhi P, et al. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(12):1634–41.CrossRefPubMedGoogle Scholar
  76. 76.
    Flint AJ, Rifat SL. The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord. 1996;36(3–4):95–105.CrossRefPubMedGoogle Scholar
  77. 77.
    Dew MA, Whyte EM, Lenze EJ, et al. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry. 2007;164(6):892–9.CrossRefPubMedGoogle Scholar
  78. 78.
    Karp JF, Whyte EM, Lenze EJ, et al. Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability. J Clin Psychiatry. 2008;69(3):457–63.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Rutherford B, Sneed J, Miyazaki M, et al. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression. Int J Geriatr Psychiatry. 2007;22(10):986–91.CrossRefPubMedGoogle Scholar
  80. 80.
    Sheffrin M, Driscoll HC, Lenze EJ, et al. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. J Clin Psychiatry. 2009;70(2):208–13.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Shamsi A, Cichon D, Obey J, et al. Pharmacotherapy for late-life depression with psychotic features: a review of literature of randomized control trials. Curr Psychiatr Rev. 2010;6(3):219–22.CrossRefGoogle Scholar
  82. 82.
    Rothschild AJ, Duval SE. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry. 2003;64(4):390–6.CrossRefPubMedGoogle Scholar
  83. 83.
    van der Wurff FB, Stek ML, et al. The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry. 2003;18(10):894–904.CrossRefPubMedGoogle Scholar
  84. 84.
    Spaans HP, Sienaert P, Bouckaert F, et al. Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. Br J Psychiatry. 2015;206(1):67–71.CrossRefPubMedGoogle Scholar
  85. 85.
    Kellner CH, Husain MM, Knapp RG, et al. Right unilateral Ultrabrief Pulse ECT in geriatric depression: phase 1 of the PRIDE Study. Am J Psychiatry. 2016;173(11):1101–9.CrossRefPubMedGoogle Scholar
  86. 86.
    Kellner CH, Husain MM, Knapp RG, et al. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE Study. Am J Psychiatry. 2016;173(11):1110–8.CrossRefPubMedGoogle Scholar
  87. 87.
    Kumar S, Mulsant BH, Liu AY, et al. Systematic review of cognitive effects of electroconvulsive therapy in late-life depression. Am J Geriatr Psychiatry. 2016;24(7):547–65.CrossRefPubMedGoogle Scholar
  88. 88.
    McDonald WM. Neuromodulation treatments for geriatric mood and cognitive disorders. Am J Geriatr Psychiatry. 2016;24(12):1130–41.CrossRefPubMedGoogle Scholar
  89. 89.
    Riva-Posse P, Hermida AP, McDonald WM. The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression. Psychiatr Clin North Am. 2013;36(4):607–30.CrossRefPubMedGoogle Scholar
  90. 90.
    Figiel GS, Epstein C, McDonald WM, et al. The use of rapid-rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. J Neuropsychiatry Clin Neurosci. 1998;10(1):20–5.CrossRefPubMedGoogle Scholar
  91. 91.
    Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34(2):522–34.CrossRefPubMedGoogle Scholar
  92. 92.
    Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005;66(9):1097–104.CrossRefPubMedGoogle Scholar
  93. 93.
    Merrill CA, Jonsson MA, Minthon L, et al. Vagus nerve stimulation in patients with Alzheimer’s disease: additional follow-up results of a pilot study through 1 year. J Clin Psychiatry. 2006;67(8):1171–8.CrossRefPubMedGoogle Scholar
  94. 94.
    Reynolds CF, Drew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006;354(11):1130–8.CrossRefPubMedGoogle Scholar
  95. 95.
    American Psychiatric Association. Desk reference to the diagnostic criteria from DSM-5, Bipolar Disorders. Washington DC: American Psychiatric Publishing; 2013. p. 65–92.Google Scholar
  96. 96.
    Montes JM, Alegria A, Garcia-Lopez A, et al. Understanding bipolar disorder in late life. J Nerv Ment Dis. 2013;201(8):674–9.CrossRefPubMedGoogle Scholar
  97. 97.
    Sajatovic M, Blow FC, Ignacio RV, Kales HC. Age-related modifiers of clinical presentation and health service use among veterans with bipolar disorder. Psychiatr Serv. 2004;55(9):1014–21.CrossRefPubMedGoogle Scholar
  98. 98.
    Sajatovic M, Chen P. Geriatric bipolar disorder. Psychiatr Clin North Am. 2011;34(2):319–33.CrossRefPubMedGoogle Scholar
  99. 99.
    Depp CA, Jin H, Mohamed S, et al. Bipolar disorder in middle-aged and elderly adults: is age of onset important? J Nerv Ment Dis. 2004;192(11):796–9.CrossRefPubMedGoogle Scholar
  100. 100.
    Yassa R, Nair V, Nastase C, et al. Prevalence of bipolar disorder in a psychogeriatric population. J Affect Disord. 1988;14(3):197–201.CrossRefPubMedGoogle Scholar
  101. 101.
    Depp CA, Lindamer LA, Folsom DP, et al. Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am J Geriatr Psychiatry. 2005;13(4):290–8.CrossRefPubMedGoogle Scholar
  102. 102.
    Depp CA, Davis CE, Mittal D, et al. Health-relate quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry. 2006;67(2):215–21.CrossRefPubMedGoogle Scholar
  103. 103.
    Räsänen P, Tiihonen J, Hakko H. The incidence and onset-age of hospitalized bipolar affective disorder in Finland. J Affect Disord. 1998;48(1):63–8.CrossRefPubMedGoogle Scholar
  104. 104.
    Almeida OP, Fenner S. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int Psychogeriatr. 2002;14(3):311–22.CrossRefPubMedGoogle Scholar
  105. 105.
    Stone K. Mania in the elderly. Br J Psychiatry. 1989;155:220–4.CrossRefPubMedGoogle Scholar
  106. 106.
    Shulman KI, Tohen M, Satlin A, et al. Mania compared with unipolar depression in old age. Am J Psychiatry. 1992;149(3):341–5.CrossRefPubMedGoogle Scholar
  107. 107.
    Tohen M, Shulman KI, Satlin A. First-episode mania in late life. Am J Psychiatry. 1994;151(1):130–2.CrossRefPubMedGoogle Scholar
  108. 108.
    García-López A, Ezquiaga E, De Dios C, Agud JL. Depressive symptoms in early- and late-onset older bipolar patients compared with younger ones. Int J Geriatr Psychiatry. 2017;32(2):201–7.CrossRefPubMedGoogle Scholar
  109. 109.
    Hays JC, Krishnan KR, George LK, Blazer DG. Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. Depress Anxiety. 1998;7(2):76–82.CrossRefPubMedGoogle Scholar
  110. 110.
    Beyer JL, Kuchibhatla M, Cassidy F, Krishnan KR. Stressful life events in older bipolar patients. Int J Geriatr Psychiatry. 2008;23(12):1271–5.CrossRefPubMedPubMedCentralGoogle Scholar
  111. 111.
    Robinson RG, Starkstein SE. Current research in affective disorders following stroke. J Neuropsychiatry Clin Neurosci. 1990;2(1):1–14.CrossRefPubMedGoogle Scholar
  112. 112.
    Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry. 1998;43(10):705–12.CrossRefPubMedGoogle Scholar
  113. 113.
    Gildengers AG, Whyte EM, Drayer RA, et al. Medical burden in late-life bipolar and major depressive disorders. Am J Geriatr Psychiatry. 2008;16(3):194–200.CrossRefPubMedPubMedCentralGoogle Scholar
  114. 114.
    Kilbourne AM, Post EP, Nossek A, et al. Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. Psychiatr Serv. 2008;59(7):760–8.CrossRefPubMedGoogle Scholar
  115. 115.
    McIntyre RS, Konarski JZ, Soczynska JK, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv. 2006;57(8):1140–4.CrossRefPubMedGoogle Scholar
  116. 116.
    Juurlink DN, Herrmann N, Szalai JP, et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004;164(11):1179–84.CrossRefPubMedGoogle Scholar
  117. 117.
    Goldstein BI, Herrmann N, Shulman KI. Comorbidity in bipolar disorder among the elderly: results from an epidemiological community sample. Am J Psychiatry. 2006;163(2):319–21.CrossRefPubMedGoogle Scholar
  118. 118.
    Young RC, Murphy CF, Heo M, et al. Cognitive impairment in bipolar disorder in old age: literature review and findings in manic patients. J Affect Disord. 2006;92(1):125–31.CrossRefPubMedGoogle Scholar
  119. 119.
    Schouws SN, Comijs HC, Dekker J, et al. Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry. 2009;17(6):508–15.CrossRefPubMedGoogle Scholar
  120. 120.
    Gildengers AG, Butters MA, Seligman K, et al. Cognitive functioning in late-life bipolar disorder. Am J Psychiatry. 2004;161(4):736–8.CrossRefPubMedGoogle Scholar
  121. 121.
    Schouws SN, Stek ML, Comijs HC, et al. Risk factors for cognitive impairment in elderly bipolar patients. J Affect Disord. 2010;125(1–3):330–5.CrossRefPubMedGoogle Scholar
  122. 122.
    Gildengers AG, Mulsant BH, Al Jurdi RK, et al. The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults. Bipolar Disord. 2010;12(8):851–8.CrossRefPubMedPubMedCentralGoogle Scholar
  123. 123.
    Bartels SJ, Forester B, Miles KM, et al. Mental health service use by elderly patients with bipolar disorder and unipolar major depression. Am J Geriatr Psychiatry. 2000;8(2):160–6.CrossRefPubMedGoogle Scholar
  124. 124.
    Kodesh A, Goldshtein I, Gelkopf M, et al. Epidemiology and comorbidity of severe mental illnesses in the community: findings from a computerized mental health registry in a large Israeli health organization. Soc Psychiatry Psychiatr Epidemiol. 2012;47(11):1775–82.CrossRefPubMedGoogle Scholar
  125. 125.
    Tsai SY, Lee CH, Kuo CJ, Chen CCA. retrospective analysis of risk and protective factors for natural death in bipolar disorder. J Clin Psychiatry. 2005;66(12):1586–91.CrossRefPubMedGoogle Scholar
  126. 126.
    Tondo L, Pompili M, Forte A, Baldessarini RJ. Suicide attempts in bipolar disorders: comprehensive review of 101 reports. Acta Psychiatr Scand. 2016;133(3):174–86.CrossRefPubMedGoogle Scholar
  127. 127.
    Clements C, Morriss R, Jones S, Peters S, Roberts C, Kapur N. Suicide in bipolar disorder in a national English sample, 1996–2009: frequency, trends and characteristics. Psychol Med. 2013;43(12):2593–602.CrossRefPubMedGoogle Scholar
  128. 128.
    Bartels SJ, Mueser KT, Miles KMA. comparative study of elderly patients with schizophrenia and bipolar disorder in nursing homes and the community. Schizophr Res. 1997;27(2–3):181–90.CrossRefPubMedGoogle Scholar
  129. 129.
    Ahearn EP, Steffens DC, Cassidy F, et al. Familial leukoencephalopathy in bipolar disorder. Am J Psychiatry. 1998;155(11):1605–7.CrossRefPubMedGoogle Scholar
  130. 130.
    Krishnan KR. Biological risk factors in late life depression. Biol Psychiatry. 2002;52(3):185–92.CrossRefPubMedGoogle Scholar
  131. 131.
    Schloesser RJ, Huang J, Klein PS, et al. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology. 2008;33(1):110–33.CrossRefPubMedGoogle Scholar
  132. 132.
    Berk M. Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol. 2009;12(4):441–5.CrossRefPubMedGoogle Scholar
  133. 133.
    Subramaniam H, Dennis MS, Byrne EJ. The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry. 2007;22(8):733–7.CrossRefPubMedGoogle Scholar
  134. 134.
    Lloyd AJ, Moore PB, Cousins DA, et al. White matter lesions in euthymic patients with bipolar disorder. Acta Psychiatr Scand. 2009;120(6):481–91.CrossRefPubMedGoogle Scholar
  135. 135.
    Tamashiro JH, Zung S, Zanetti MV, et al. Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord. 2008;10(7):765–75.CrossRefPubMedGoogle Scholar
  136. 136.
    Sarnicola A, Kempton M, Germana C, et al. No differential effect of age on brain matter volume and cognition in bipolar patients and healthy individuals. Bipolar Disord. 2009;11(3):316–22.CrossRefPubMedGoogle Scholar
  137. 137.
    Young RC, Nambudiri DE, Jain H, et al. Brain computed tomography in geriatric manic disorder. Biol Psychiatry. 1999;45:1063–5.CrossRefPubMedGoogle Scholar
  138. 138.
    Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–5.CrossRefPubMedGoogle Scholar
  139. 139.
    Zimmerman M, Ruggero CJ, Galione JN, et al. Detecting differences in diagnostic assessment of bipolar disorder. J Nerv Ment Dis. 2010;198(5):339–42.CrossRefPubMedGoogle Scholar
  140. 140.
    Baldassano CF. Assessment tools for screening and monitoring bipolar disorder. Bipolar Disord. 2005;7(Suppl 1):8–15.CrossRefPubMedGoogle Scholar
  141. 141.
    Picardi A. Rating scales in bipolar disorder. Curr Opin Psychiatry. 2009;22(1):42–9.CrossRefPubMedGoogle Scholar
  142. 142.
    Berk M, Malhi GS, Cahill C, et al. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disord. 2007;9(6):571–9.CrossRefPubMedGoogle Scholar
  143. 143.
    Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35.CrossRefPubMedGoogle Scholar
  144. 144.
    Miklowitz DJ. A review of evidence-based psychosocial interventions for bipolar disorder. J Clin Psychiatry. 2006;67(Suppl 11):28–33.PubMedGoogle Scholar
  145. 145.
    Lauder SD, Berk M, Castle DJ, et al. The role of psychotherapy in bipolar disorder. Med J Aust. 2010;193(4 Suppl):S31–5.PubMedGoogle Scholar
  146. 146.
    Depp CA, Lebowitz BD, Patterson TL, et al. Medication adherence skills training for middle-aged and elderly adults with bipolar disorder: development and pilot study. Bipolar Disord. 2007;9(6):636–45.CrossRefPubMedGoogle Scholar
  147. 147.
    Kilbourne AM, Post EP, Nossek A, et al. Service delivery in older patients with bipolar disorder: a review and development of a medical care model. Bipolar Disord. 2008;10(6):672–83.CrossRefPubMedGoogle Scholar
  148. 148.
    Aziz R, Lorberg B, Tampi RR. Treatment for late-life bipolar disorder. Am J Geriatr Pharmacother. 2006;4(4):347–64.CrossRefPubMedGoogle Scholar
  149. 149.
    Dols A, Kessing LV, Strejilevich SA, et al. Do current national and international guidelines have specific recommendations for older adults with bipolar disorder? A brief report. Int J Geriatr Psychiatry. 2016;31(12):1295–300.CrossRefPubMedGoogle Scholar
  150. 150.
    Sajatovic M, Madhusoodanan S, Coconcea N. Managing bipolar disorder in the elderly: defining the role of the newer agents. Drugs Aging. 2005;22(1):39–54.CrossRefPubMedGoogle Scholar
  151. 151.
    Sajatovic M. Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry. 2002;17(9):865–73.CrossRefPubMedGoogle Scholar
  152. 152.
    Kessing LV, Søndergård L, Kvist K, et al. Suicide risk in patients treated with lithium. Arch Gen Psychiatry. 2005;62(8):860–6.CrossRefPubMedGoogle Scholar
  153. 153.
    Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord. 2010;12(1):87–94.CrossRefPubMedGoogle Scholar
  154. 154.
    Eastham JH, Jeste DV, Young RC. Assessment and treatment of bipolar disorder in the elderly. Drugs Aging. 1998;12(3):205–24.CrossRefPubMedGoogle Scholar
  155. 155.
    American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(Suppl 4):1–50.Google Scholar
  156. 156.
    Shulman KI, Rochon P, Sykora K, et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ. 2003;326(7396):960–1.CrossRefPubMedPubMedCentralGoogle Scholar
  157. 157.
    Chen ST, Altshuler LL, Melnyk KA, et al. Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study. J Clin Psychiatry. 1999;60(3):181–6.CrossRefPubMedGoogle Scholar
  158. 158.
    Schneider AL, Wilcox CS. Divalproate augmentation in lithium-resistant rapid cycling mania in four geriatric patients. J Affect Disord. 1998;47(1–3):201–5.CrossRefPubMedGoogle Scholar
  159. 159.
    Goldberg JF, Sacks MH, Kocsis JH. Low-dose lithium augmentation of divalproex in geriatric mania. J Clin Psychiatry. 2000;61(4):304.CrossRefPubMedGoogle Scholar
  160. 160.
    Greil W, Kleindienst N, Erazo N, et al. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol. 1998;18(6):455–60.CrossRefPubMedGoogle Scholar
  161. 161.
    Vasudev K, Goswami U, Kohli K. Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder. Psychopharmacology. 2000;150(1):15–23.CrossRefPubMedGoogle Scholar
  162. 162.
    Sajatovic M, Gyulai L, Calabrese JR, et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry. 2005;13(4):305–11.CrossRefPubMedGoogle Scholar
  163. 163.
  164. 164.
    McIntyre RS, Cha DS, Kim RD, Mansur RB. A review of FDA-approved treatment options in bipolar depression. CNS Spectr. 2013;18(Suppl 1):4–20. quiz 21PubMedGoogle Scholar
  165. 165.
    Madhusoodanan S, Brenner R, Araujo L, et al. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry. 1995;56(11):514–8.PubMedGoogle Scholar
  166. 166.
    Shulman RW, Singh A, Shulman KI. Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol Bull. 1997;33(1):113–8.PubMedGoogle Scholar
  167. 167.
    Sajatovic M, Calabrese JR, Mullen J. Quetiapine for the treatment of bipolar mania in older adults. Bipolar Disord. 2008;10(6):662–71.CrossRefPubMedGoogle Scholar
  168. 168.
    Sajatovic M, Dines P, Fuentes-Casiano E, et al. Asenapine in the treatment of older adults with bipolar disorder. Int J Geriatr Psychiatry. 2015;30(7):710–9.CrossRefPubMedGoogle Scholar
  169. 169.
    Sajatovic M, Forester BP, Tsai J, et al. Efficacy of lurasidone in adults aged 55 years and older with bipolar depression: post hoc analysis of 2 double-blind, placebo-controlled studies. J Clin Psychiatry. 2016;77(10):e1324–31.CrossRefPubMedGoogle Scholar
  170. 170.
    Mittal V, Kurup L, Williamson D, et al. Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence. Am J Alzheimers Dis Other Demen. 2011;26(1):10–28.CrossRefPubMedGoogle Scholar
  171. 171.
    Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry. 2004;161(9):1537–47.CrossRefPubMedGoogle Scholar
  172. 172.
    Schaffer A, Mamdani M, Levitt A, et al. Effect of antidepressant use on admissions to hospital among elderly bipolar patients. Int J Geriatr Psychiatry. 2006;21(3):275–80.CrossRefPubMedGoogle Scholar
  173. 173.
    Zhang Y, Yang H, Yang S, et al. Antidepressants for bipolar disorder: a meta-analysis of randomized, double-blind, controlled trials. Neural Regen Res. 2013;8(31):2962–74.PubMedPubMedCentralGoogle Scholar
  174. 174.
    Morishita S, Aoki S. Clonazepam augmentation of antidepressants: does it distinguish unipolar from bipolar depression? J Affect Disord. 2002;71(1–3):217–20.CrossRefPubMedGoogle Scholar
  175. 175.
    Winkler D, Willeit M, Wolf R, et al. Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder. Eur Neuropsychopharmacol. 2003;13(2):129–34.CrossRefPubMedGoogle Scholar
  176. 176.
    Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry. 1994;151(2):169–76.CrossRefPubMedGoogle Scholar
  177. 177.
    Fraser RM, Glass IB. Unilateral and bilateral ECT in elderly patients. A comparative study. Acta Psychiatr Scand. 1980;62:13–31.CrossRefPubMedGoogle Scholar
  178. 178.
    Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. 2004;12(4):342–57.CrossRefPubMedGoogle Scholar
  179. 179.
    Gildengers AG, Mulsant BH, Begley AE, et al. A pilot study of standardized treatment in geriatric bipolar disorder. Am J Geriatr Psychiatry. 2005;13(4):319–23.CrossRefPubMedGoogle Scholar
  180. 180.
    Rej S, Herrmann N, Shulman K, et al. Current psychotropic medication prescribing patterns in late-life bipolar disorder. Int J Geriatr Psychiatry. 2016.Google Scholar
  181. 181.
    Sajatovic M, Strejilevich SA, Gildengers AG, et al. A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disord. 2015;17(7):689–704.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Rajesh R. Tampi
    • 1
  • Deena J. Tampi
    • 3
  • M. Ingre Walters
    • 4
  • Geetha Manikkara
    • 2
  • Poorvanshi Alag
    • 1
  • Garima Garg
    • 1
  1. 1.Case Western Reserve University School of Medicine and MetrohealthClevelandUSA
  2. 2.MetrohealthClevelandUSA
  3. 3.Diamond HealthcareRichmondUSA
  4. 4.Lewis Katz School of Medicine at Temple UniversityPhiladelphiaUSA

Personalised recommendations